350 related articles for article (PubMed ID: 22385398)
21. Choice of contraceptives.
Med Lett Drugs Ther; 2015 Sep; 57(1477):127-32. PubMed ID: 26353044
[No Abstract] [Full Text] [Related]
22. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
[TBL] [Abstract][Full Text] [Related]
23. [State of the hypothalamo-hypophyseal-ovarian system in young nullipara women with ectopia of the cervix of uterus during taking the hormonal contraceptives].
Djangidze M; Djugeli M; Museridze N; Zakaraia L
Georgian Med News; 2007 Oct; (151):26-31. PubMed ID: 18071207
[TBL] [Abstract][Full Text] [Related]
24. The sexuological impact of hormonal contraceptives based on their route of administration.
Guida M; Di Carlo C; Troisi J; Gallo A; Cibarelli F; Martini E; Tiranini L; Nappi RE
Gynecol Endocrinol; 2017 Mar; 33(3):218-222. PubMed ID: 27908210
[TBL] [Abstract][Full Text] [Related]
25. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A
Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124
[TBL] [Abstract][Full Text] [Related]
26. [Safety evaluation of a transdermal contraceptive system with an oral contraceptive].
Radowicki S; Skórzewska K; Szlendak K
Ginekol Pol; 2005 Nov; 76(11):884-9. PubMed ID: 16566363
[TBL] [Abstract][Full Text] [Related]
27. Impact of hormonal contraceptives vis-à-vis non-hormonal factors on the vitamin status of malnourished women in India and Thailand. World Health Organization: Special Programme of Research, Development and Research Training in Human Reproduction. Task Force on Oral Contraceptives.
Joshi UM; Virkar KD; Amatayakul K; Singkamani R; Bamji MS; Prema K; Whitehead TP; Belsey MA; Hall P; Parker RA
Hum Nutr Clin Nutr; 1986 May; 40(3):205-20. PubMed ID: 3087915
[TBL] [Abstract][Full Text] [Related]
28. [Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
Plu-Bureau G; Sabbagh E; Hugon-Rodin J
Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):823-833. PubMed ID: 30389542
[TBL] [Abstract][Full Text] [Related]
29. Serum lipid studies in women using combination type of oral contraceptives.
Vaidya R; Purandare VN; Nain S; Gupta K; Rajwade N; Sheth UK
J Obstet Gynaecol India; 1979 Jun; 29(3):644-6. PubMed ID: 12335922
[TBL] [Abstract][Full Text] [Related]
30. Transdermal ethinylestradiol/norelgestromin: a review of its use in hormonal contraception.
Goa KL; Warner GT; Easthope SE
Treat Endocrinol; 2003; 2(3):191-206. PubMed ID: 15966567
[TBL] [Abstract][Full Text] [Related]
31. Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10.
Lidegaard O; Nielsen LH; Skovlund CW; Løkkegaard E
BMJ; 2012 May; 344():e2990. PubMed ID: 22577198
[TBL] [Abstract][Full Text] [Related]
32. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
Middeldorp S; Meijers JC; van den Ende AE; van Enk A; Bouma BN; Tans G; Rosing J; Prins MH; Büller HR
Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
[TBL] [Abstract][Full Text] [Related]
33. Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
Tepper NK; Dragoman MV; Gaffield ME; Curtis KM
Contraception; 2017 Feb; 95(2):130-139. PubMed ID: 27771476
[TBL] [Abstract][Full Text] [Related]
34. Antidepressant dispensing trends in New Zealand between 2004 and 2007.
Exeter D; Robinson E; Wheeler A
Aust N Z J Psychiatry; 2009 Dec; 43(12):1131-40. PubMed ID: 20001412
[TBL] [Abstract][Full Text] [Related]
35. Continuation rates of oral hormonal contraceptives in a cohort of first-time users: a population-based registry study, Sweden 2005-2010.
Josefsson A; Wiréhn AB; Lindberg M; Foldemo A; Brynhildsen J
BMJ Open; 2013 Oct; 3(10):e003401. PubMed ID: 24141970
[TBL] [Abstract][Full Text] [Related]
36. Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
Jick S; Kaye JA; Li L; Jick H
Contraception; 2007 Jul; 76(1):4-7. PubMed ID: 17586129
[TBL] [Abstract][Full Text] [Related]
37. Abnormal uterine bleeding associated with hormonal contraception.
Schrager S
Am Fam Physician; 2002 May; 65(10):2073-80. PubMed ID: 12046776
[TBL] [Abstract][Full Text] [Related]
38. Desogestrel+ethinylestradiol versus levonorgestrel+ethinylestradiol. Which one has better affect on acne, hirsutism, and weight change.
Sanam M; Ziba O
Saudi Med J; 2011 Jan; 32(1):23-6. PubMed ID: 21212911
[TBL] [Abstract][Full Text] [Related]
39. Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.
Sidney S; Cheetham TC; Connell FA; Ouellet-Hellstrom R; Graham DJ; Davis D; Sorel M; Quesenberry CP; Cooper WO
Contraception; 2013 Jan; 87(1):93-100. PubMed ID: 23083525
[TBL] [Abstract][Full Text] [Related]
40. Hormonal contraceptive discontinuation patterns according to formulation: investigation of associations in an administrative claims database.
Murphy PA; Brixner D
Contraception; 2008 Apr; 77(4):257-63. PubMed ID: 18342648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
